Posts

Posted on

Cal-Maine Foods, Inc. Announces $40.1 Million Capital Project to Expand Cage-Free Production in Kentucky

Cal-Maine Foods, Inc. Announces $40.1 Million Capital Project to Expand Cage-Free Production in Kentucky

JACKSON, Miss.–(BUSINESS WIRE)–
Cal-Maine Foods, Inc. (NASDAQ: CALM) today announced that its Board of Directors has approved a $40.1 million capital project to expand the Company’s cage-free egg production at its Guthrie, Kentucky, production facility. The project will include related site work and the additional infrastructure to convert existing conventional capacity to house approximately 1.5 million cage-free hens and 300,000 pullets. Construction will commence immediately with initial conversions expected in early 2021, first pullet placements by summer 2021 and the first layer house finished by fall 2021. Project completion is expected by late 2022. The Company plans to fund the project through a combination of available cash on hand, investments, and operating cash flow.

Commenting on the announcement, Dolph Baker, chairman and chief executive officer of Cal-Maine Foods, Inc., stated, “This latest expansion supports our continued efforts to position Cal-Maine Foods as an industry leader in meeting future customer goals for cage-free eggs. The Guthrie location is strategically located close to a large customer footprint, which will enable us to enhance our distribution of cage-free eggs for this important market region. Including this latest project, we have allocated approximately $462.5 million during the prior twelve years to facilities, equipment, and related operations to expand our cage-free production. Across the country, a growing number of states have passed minimum space and/or cage-free requirements with implementations ranging from January 2022 to January 2026. We believe adding this capacity in Cal-Maine Foods’ facilities over the next two years will help drive our continued efforts to meet customers’ needs.”

Cal-Maine Foods, Inc. is primarily engaged in the production, grading, packing and sale of fresh shell eggs, including conventional, cage-free, organic and nutritionally enhanced eggs. The Company, which is headquartered in Jackson, Mississippi, is the largest producer and distributor of fresh shell eggs in the United States and sells the majority of its shell eggs in states across the southwestern, southeastern, mid-western and mid-Atlantic regions of the United States.

Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s SEC filings (including its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K), (ii) the risks and hazards inherent in the shell egg business (including disease, pests, weather conditions and potential for recall), (iii) changes in the demand for and market prices of shell eggs and feed costs, (iv) our ability to predict and meet demand for cage-free and other specialty eggs, (v) risks, changes or obligations that could result from our future acquisition of new flocks or businesses and risks or changes that may cause conditions to completing a pending acquisition not to be met,(vi) risks relating to the evolving COVID-19 pandemic, and (vii) adverse results in pending litigation matters. SEC filings may be obtained from the SEC or the Company’s website, www.calmainefoods.com. Readers are cautioned not to place undue reliance on forward-looking statements because, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. Further, the forward-looking statements included herein are only made as of the respective dates thereof, or if no date is stated, as of the date hereof. Except as otherwise required by law, we disclaim any intent or obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise.

Dolph Baker, Chairman and CEO

Max P. Bowman, Vice President and CFO

(601) 948-6813

KEYWORDS: United States North America Mississippi Kentucky

INDUSTRY KEYWORDS: Retail Agriculture Natural Resources Food/Beverage

MEDIA:

Logo
Logo
Posted on

Whitestone Added 9,000 Square Feet of New Tenants at Shops of Starwood Increasing NOI by 16% at the Center and Capitalizing on the Supercharged Growth in Frisco, TX

HOUSTON, Dec. 15, 2020 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) continues to grow occupancy by drawing expanding businesses to its properties located in the high growth markets of Frisco, TX and other surrounding areas of Dallas.

Continuing its resiliency despite the pandemic, Whitestone is pleased to announce local realtors Re/Max DFW Associates and United Real Estate Dallas are opening at The Shops of Starwood to expand their businesses and capture additional market share from the national trend of businesses and consumers fleeing high tax, high regulatory cities for the business-friendlier confines of Dallas and its surrounding communities. These additions increase occupancy at the center to 100%, and will contribute 16% additional NOI in 2021.

According to Bisnow, recent corporate moves to the DFW area are:

PGA
McKesson
Charles Schwab
Uber
Core-Mark

Whitestone owns properties in proximity to all of these locations.

A November 30th article by Cushman & Wakefield, “Corporate Migration to Texas” ranked the Dallas/Ft Worth area first for corporate migration, citing factors like Favorable Tax Environment, Affordable Housing and Quality of Education, Accessibility, and Real Estate as major reasons why corporations are moving to this high growth city. With a growth rate of over 71% over the last 10 years according to the Dallas Morning News, local realtors have taken notice and are adjusting accordingly.

Whitestone’s The Shops at Starwood is surrounded by luxury living and a robust daytime workforce. Located in thriving Frisco, which was voted The #1 Best Place to Live in America by Money Magazine in September of 2018, The Shops of Starwood is in a desirable neighborhood where the average household income is over $178,000 and home values are in excess of $600,000. The Shops at Starwood provides a unique mix of convenience and elegance and is home to a variety of award-winning restaurants, including TruFire, Kotta Sushi, J. Theodore’s, Bottled in Bond and Tupy’s.

Whitestone Chairman and CEO Jim Mastandrea commented, “With these corporate moves, the value of Whitestone’s real estate continues to increase as additional foot traffic is driving leasing, and leasing is driving revenues. According to research done with Placer.ai, the traffic at Starwood has rebounded to approximately 90% of pre-COVID levels, lending to the robustness and the resiliency of our markets.”

RE/MAX DFW Associates is moving into a larger office at the higher profile property of The Shops at Starwood to be their base of operations. Owners Mark & Kay Wolfe will be employing approximately 125 agents based at The Shops at Starwood office and will focus on the surrounding Collin County market.

United Real Estate Dallas is also expanding by opening its second office in the metroplex. They presently boast over 500 agents in the metroplex and opening a second location in Frisco will expedite their North Dallas growth strategy.


About Whitestone REIT
 
Whitestone is a community-centered shopping center REIT that acquires, owns, manages, develops and redevelops high-quality neighborhood centers primarily in the largest, fastest-growing and most affluent markets in the Sunbelt. 

Whitestone seeks to create Communities That Thrive through Creating Local Connections between consumers in the surrounding communities and a well-crafted mix of national, regional and local tenants that provide daily necessities, needed services, entertainment and experiences. 

Whitestone is a monthly dividend paying stock and has consistently paid dividends for over 15 years.

Whitestone’s strong balanced and managed capital structure provides stability and flexibility for growth and positions Whitestone to perform well through economic cycles. For additional information, please visit www.whitestonereit.com 


About RE/MAX DFW Associates
 
RE/MAX DFW Associates is the largest RE/MAX Company not only in the Texas real estate market but throughout the entire Southwestern United States RE/MAX DFW Realtors have been guiding home buyers and home sellers through the real estate process for over 30 years Our offices are located “deep in the heart of Texas” in the Dallas, Flower Mound, Coppell, Las Colinas, Carrollton, Plano and Frisco real estate markets.


About United Real Estate Dallas
 
United Real Estate Dallas is part of the largest fully integrated network of real estate and auction professionals in the nation. The company has been an innovator in real estate marketing since 1925. Our Management team knows the needs of agents in urban and metropolitan markets. We address those needs by providing powerful marketing programs along with technology-based services that are unique to the industry. For additional information, please visit www.unitedrealestatedallas.com


About Placer.ai


Silicon Valley-based Placer.ai is the most advanced foot traffic analytics platform allowing anyone with a stake in the physical world to instantly generate insights into any property for a deeper understanding of the factors that drive success. Placer.ai is the first platform that fully empowers professionals in retail, commercial real estate, hospitality, economic development and more to truly understand and maximize their offline activities. Find more information here: https://placer.ai/  

Investors Contact:

Kevin Reed, Director of Investor Relations
Whitestone REIT
(713) 435-2219
[email protected]



Posted on

Medalist Diversified REIT Announces Extension of Clemson University Rental Agreement Through May 2021 for Its Clemson Best Western Property

Medalist Diversified REIT Announces Extension of Clemson University Rental Agreement Through May 2021 for Its Clemson Best Western Property

RICHMOND, Va.–(BUSINESS WIRE)–Medalist Diversified REIT, Inc. (NASDAQ: MDRR) (the “Company” or “Medalist”), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Southeast region of the U.S., today announced that it has extended its rental agreement with Clemson University for the Company’s Clemson Best Western Plus property. Under the terms of the agreement, the university has agreed to extend its rental contract for the entire 148-room Clemson Best Western Plus property through May 5, 2021.

“We are very pleased to continue our relationship with Clemson University,” stated Thomas E. Messier, Chairman and Chief Executive Officer of Medalist. “While many in our industry continue to struggle from the impact of COVID-19, our focus on secondary and tertiary markets in the southeast, combined with mutually beneficial agreements such as this contract with Clemson, have enabled us to continue to outperform many of our peers, placing us in a great position to further expand our portfolio in 2021 and beyond.”

About Medalist Diversified REIT

Medalist Diversified REIT Inc. is a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Mid-Atlantic and Southeast regions. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the southeast for acquisition opportunities and disposal of properties as considered appropriate. For more information on Medalist, please visit the Company website at https://www.medalistreit.com.

Forward Looking Statements

This press release contains statements that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward looking statements are statements that are not historical, including statements regarding management’s intentions, beliefs, expectations, representations, plans or predictions of the future, and are typically identified by such words as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “will,” “should” and “could.” Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward looking statements. These forward-looking statements are based upon the Company’s present expectations, but these statements are not guaranteed to occur, including, without limitation, with respect to the completion of the proposed public offering on the terms described or at all. Furthermore, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes. Investors should not place undue reliance upon forward-looking statements. For further discussion of the factors that could affect outcomes, please refer to the “Risk Factors” section of the prospectus dated February 13, 2020, and in the Company’s subsequent annual and periodic reports and other documents filed with the SEC, copies of which are available on the SEC’s website, www.sec.gov.

Dave Gentry, CEO

RedChip Companies Inc.

407-491-4498

[email protected]

 

KEYWORDS: Virginia South Carolina United States North America

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Posted on

TFI International Declares Quarterly Dividend

MONTREAL, Dec. 15, 2020 (GLOBE NEWSWIRE) — The Board of Directors of TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, declared a quarterly dividend of CAD $0.29 per outstanding common share of its capital payable on January 15, 2021 to shareholders of record at the close of business on December 31, 2020. As announced October 22, 2020, the new quarterly dividend of CAD $0.29 per outstanding common share represents an increase over the previous quarterly dividend of CAD $0.26 per outstanding common share.

ABOUT TFI INTERNATIONAL
TFI International Inc. is a North American leader in the transportation and logistics industry, operating across the United States, Canada and Mexico through its subsidiaries. TFI International creates value for shareholders by identifying strategic acquisitions and managing a growing network of wholly-owned operating subsidiaries. Under the TFI International umbrella, companies benefit from financial and operational resources to build their businesses and increase their efficiency. TFI International companies service the following segments:

  • Package and Courier;
  • Less-Than-Truckload;
  • Truckload;
  • Logistics.

TFI International Inc. is publicly traded on the New York Stock Exchange and the Toronto Stock Exchange under the symbol TFII. For more information, visit www.tfiintl.com.

For further information:

Alain Bédard
Chairman, President and CEO
TFI International Inc.
647-729-4079
[email protected]

 



Posted on

ArcelorMittal Enters into Separate, Privately Negotiated Agreements with Certain Holders of its 5.50% Mandatorily Convertible Subordinated Notes due 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.

15 December, 2020, 22:40 CET

ArcelorMittal (the “Company” or “ArcelorMittal”) announced today that the Company has entered into separate, privately negotiated exchange agreements with a limited number of holders of the Company’s 5.50% Mandatorily Convertible Subordinated Notes due 2023 (the “Notes”).

Pursuant to the exchange agreements, the Company will exchange $246.8 million in aggregate principal amount of the Notes, for an aggregate of (i) 22,653,933 shares (all existing shares held in treasury) of ArcelorMittal common stock (i.e. the minimum conversion ratio under the Notes) plus (ii) $25.4 million (including accrued interest on the exchanged Notes up to, but excluding, the settlement date). The Company will not receive any proceeds from the delivery of such shares of common stock. The exchanges are expected to close on or about 22 December 2020, subject to customary closing conditions. Following completion of the exchanges, approximately $1.0 billion aggregate principal amount of the Notes will remain outstanding.

ENDS

Important Information

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

The securities being offered pursuant to the transaction described in this press release (the “Securities”) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (“Securities Act”), or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, resold, delivered or otherwise distributed absent registration, except in reliance on an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offering of the Securities in the United States or elsewhere.

This press release is for distribution only to persons who (a) have professional experience in matters relating to investments falling within Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”); (b) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”) of the Order; (c) are outside the United Kingdom (“UK”); or (d) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This press release is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this press release relates is available only to relevant persons and will be engaged in only with relevant persons.

This press release is only addressed to and directed at persons in member states of the European Economic Area (“EEA”) and in the UK who are “Qualified Investors” within the meaning of Article 2(e) of the Prospectus Regulation. The Securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Securities will be engaged in only with Qualified Investors. This press release must not be acted on or relied on in any member state of the EEA or in the UK by persons who are not Qualified Investors. For the purposes of this provision the expression “Prospectus Regulation” means Regulation (EU) 2017/1129 (as amended or superseded). References in this press release to regulations or directives include, in relation to the UK, those regulations or directives as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 or have been implemented in UK domestic law, as appropriate.

No public offering of the Securities is being made in the United Kingdom. In the United Kingdom, all offers of the Securities will be made pursuant to an exemption under the Prospectus Regulation (as defined above) from the requirement to produce a prospectus. No prospectus will be made available in connection with the transaction and no such prospectus is required to be published in accordance with the Prospectus Regulation.

The distribution of this press release and the offering of the Securities in certain jurisdictions may be restricted by law. No action has been taken by the Company that would permit an offering of such Securities or possession or distribution of this press release or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this press release comes are required by the Company to inform themselves about, and to observe, such restrictions.

The information contained in this press release is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained in it and nor does it intend to. This press release does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Securities. Any investment decision to participate in the transaction and acquire the Securities must be made solely on the basis of publicly available information.

The information in this press release may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction or disclosure of this information in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions. This press release does not represent the announcement of a definitive agreement to proceed with the transaction and, accordingly, there can be no certainty that the transaction will proceed. The Company reserves the right not to proceed with the transaction or to vary any terms of the transaction in any way.

NOTWITHSTANDING ANYTHING IN THE FOREGOING, NO PUBLIC OFFERING OF THE SECURITIES IS BEING MADE BY ANY PERSON ANYWHERE AND THE COMPANY HAS NOT AUTHORIZED OR CONSENTED TO ANY SUCH OFFERING IN RELATION TO THE SECURITIES.


About ArcelorMittal

ArcelorMittal is the world’s leading steel and mining company, with a presence in 60 countries and primary steelmaking facilities in 18 countries. In 2019, ArcelorMittal had revenues of U.S.$70.6 billion and crude steel production of 89.8 million metric tonnes, while iron ore production reached 57.1 million metric tonnes.

Our goal is to help build a better world with smarter steels. Steels made using innovative processes which use less energy, emit significantly less carbon and reduce costs. Steels that are cleaner, stronger and reusable. Steels for electric vehicles and renewable energy infrastructure that will support societies as they transform through this century. With steel at our core, our inventive people and an entrepreneurial culture at heart, we will support the world in making that change. This is what we believe it takes to be the steel company of the future.

ArcelorMittal is listed on the stock exchanges of New York (MT), Amsterdam (MT), Paris (MT), Luxembourg (MT) and on the Spanish stock exchanges of Barcelona, Bilbao, Madrid and Valencia (MTS).



For more information about ArcelorMittal please visit:


http://corporate.arcelormittal.com/



 		  
Contact information ArcelorMittal Investor Relations  
   
Europe +44 20 7543 1156
Americas +1 312 899 3985
Retail +44 20 7543 1156
SRI +44 20 7543 1156
Bonds/Credit +33 171 921 026
   
   
Contact information ArcelorMittal Corporate Communications  
 

E-mail:

  

[email protected]
Phone: +442076297988
   
   
ArcelorMittal Communications

 

 
Paul Weigh

 

 +44 20 3214 2419

 



Posted on

Middlesex Water Company Names Dr. Joshua Bershad to Its Board of Directors

ISELIN, N.J., Dec. 15, 2020 (GLOBE NEWSWIRE) — Dr. Joshua Bershad, Executive Vice President, Physician Services, RWJBarnabas Health and Chief Medical Officer, Rutgers Athletics, has been named to the Board of Directors of Middlesex Water Company, (NASDAQ:MSEX). Dr. Bershad’s term is effective immediately and will remain in effect until the Annual Meeting of Shareholders on May 25, 2021 at which time he will stand for election as a Class III Director for the remaining two years of the three-year term of a Class III Director.

In addition to his role with RWJBarnabas Health and Rutgers Athletics, Dr. Bershad teaches in multiple capacities at Rutgers University, including as Clinical Assistant Professor of Medicine at Rutgers-Robert Wood Johnson Medical School, as Adjunct Clinical Professor at Rutgers-Ernest Mario School of Pharmacy, and as Visiting Lecturer at Rutgers Business School EMBA Program. Previously, he served in multiple senior executive roles within Robert Wood Johnson University Hospital & Health System, including Senior Vice President/Chief Medical Officer and Chair of the Medical Executive Committee for approximately 10 years. He was the organizer and initial President of RWJ Physician Enterprise, a multispecialty physician group.

“We are pleased to welcome Dr. Bershad to our Board,” said Dennis W. Doll, Chairman, President and Chief Executive Officer of Middlesex Water. “His expertise complements the broad-based backgrounds and skills of our existing Directors. As a public utility whose role is critical in public health protection, we look forward to the counsel Joshua will provide to our team and his contributions to our Company’s continued growth and success,” added Doll.

Dr. Bershad serves as a member of the Board of Directors of the Middlesex County Medical Society and is Chairman of the Board of Directors of Robert Wood Johnson Visiting Nurses. He also is a member of the Board of Trustees of the VNA Health Group. Dr. Bershad attended both Rutgers Medical School and Rutgers Business School where he received his MD and MBA, respectively. He also holds a Bachelor’s degree in Biology/Geology from the State University of New York (SUNY) Binghamton.


About Middlesex Water Company


Established in 1897, Middlesex Water Company serves as a trusted provider offering life-sustaining high quality water service for residential, commercial, industrial and fire protection purposes. The Company offers a full range of water, wastewater utility and related services. An investor-owned public utility, Middlesex Water is a professional services provider specializing in municipal and industrial contract operations and water and wastewater system technical operations and maintenance. The company and its subsidiaries form the Middlesex Water family of companies, which collectively serve a population of nearly half a million people in New Jersey and Delaware.  Named a 2020 Top Workplace in New Jersey, Middlesex is diligently focused on meeting and balancing the needs of our employees, customers, and shareholders. We invest in our people, our infrastructure and the communities we serve to support reliable and resilient utility services, economic growth and quality of life.  To learn more, visit our website and follow us on Facebook, Twitter and LinkedIn.
         
Media Contact:
Bernadette M. Sohler, Vice President – Corporate Affairs
(732) 638-7549
www.middlesexwater.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b5ce18fc-9c68-4b5b-ba4d-0f568e2e31c3

 



Posted on

TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock and Series B Cumulative Redeemable Preferred Stock

TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock and Series B Cumulative Redeemable Preferred Stock

NEW YORK–(BUSINESS WIRE)–
TPG RE Finance Trust, Inc. (NYSE: TRTX) (“TRTX” or the “Company”) announced that on December 15, 2020, the Company’s Board of Directors declared a cash dividend of $0.20 per share of common stock for the fourth quarter of 2020. The Board of Directors also approved an additional, non-recurring special cash dividend of approximately $14.0 million, or $0.18 per share of common stock, attributable to the Company’s estimated 2020 REIT taxable income which was previously undistributed. The full fourth quarter dividend, regular and special, will be payable on January 22, 2021 to common stockholders of record as of December 28, 2020.

On December 15, 2020, the Company’s Board of Directors also declared a cash dividend of $0.69 per share of 11% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred”) for the quarterly period ending December 30, 2020. The Series B Preferred dividend is payable on December 31, 2020 to the Series B Preferred stockholder of record as of December 15, 2020.

ABOUT TRTX

TPG RE Finance Trust, Inc. is a commercial real estate finance company that originates, acquires, and manages primarily first mortgage loans secured by institutional properties located in primary and select secondary markets in the United States. The Company is externally managed by TPG RE Finance Trust Management, L.P., a part of TPG Real Estate, which is the real estate investment platform of global alternative asset firm TPG. For more information regarding TRTX, visit http://investors.tpgrefinance.com/.

FORWARD-LOOKING STATEMENTS

The information contained in this press release contains “forward‐looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to various risks and uncertainties, including, without limitation, statements relating to the performance of the investments of the Company; the ultimate geographic spread, severity and duration of pandemics such as the recent outbreak of novel coronavirus (“COVID-19”), actions that may be taken by governmental authorities to contain or address the impact of such pandemics, and the potential negative impacts of such pandemics on the global economy and the Company’s financial condition and results of operations; the Company’s ability to originate loans that are in the pipeline and under evaluation by the Company; and financing needs and arrangements. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “may,” “will,” “should,” “potential,” “intend,” “expect,” “endeavor,” “seek,” “anticipate,” “estimate,” “believe,” “could,” “project,” “predict,” “continue” or other similar words or expressions. Forward-looking statements are based on certain assumptions, discuss future expectations, describe existing or future plans and strategies, contain projections of results of operations, liquidity and/or financial condition or state other forward-looking information. Statements, among others, relating to the continuing impact of COVID-19 on the Company’s business, financial condition and results of operations and the Company’s ability to generate future growth and deliver returns are forward-looking statements, and the Company cannot assure you that TRTX will achieve such results. The ability of TRTX to predict future events or conditions or their impact or the actual effect of existing or future plans or strategies is inherently uncertain. Although the Company believes that such forward-looking statements are based on reasonable assumptions, actual results and performance in the future could differ materially from those set forth in or implied by such forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company’s views only as of the date of this press release. Except as required by law, neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements appearing in this press release. The Company does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

INVESTOR RELATIONS CONTACT

+1 (212) 405-8500

[email protected]

MEDIA CONTACT

TPG RE Finance Trust, Inc.

Courtney Power

+1 (415) 743-1550

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: REIT Finance Professional Services Commercial Building & Real Estate Construction & Property

MEDIA:

Posted on

Pulse Biosciences Grants Equity Incentive Awards To New Employees

Pulse Biosciences Grants Equity Incentive Awards To New Employees

HAYWARD, Calif.–(BUSINESS WIRE)–
Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”) a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 40,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on December 15, 2020.

The 2017 Inducement Equity Incentive Plan is used exclusively to grant equity awards to individuals who were not previously an employee or non-employee director of Pulse Biosciences as an inducement material to such individual’s entering into employment with Pulse Biosciences in accordance with Nasdaq Marketplace Rule 5635(c)(4).

The options have an exercise price of $18.40 per share, which is equal to the closing price of Pulse Biosciences common stock on December 15, 2020. The 40,250 shares underlying the option grants will vest and become exercisable as to 25% of the shares annually beginning on the first anniversary of the recipient’s start date, subject to the recipient’s continued employment with Pulse Biosciences on these vesting dates. The options are subject to the terms and conditions of the 2017 Inducement Equity Incentive Plan and the award agreements entered into with each recipient.

About Pulse Biosciences®

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients. If cleared, the CellFX® System will be the first commercial product to harness the distinctive advantages of the Company’s proprietary Nano-Pulse Stimulation™ technology to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. Subject to regulatory approval, the initial commercial use of the CellFX System is expected to address a broad range of dermatologic conditions that share high demand among patients and practitioners for improved and durable aesthetic outcomes. Designed as a multi-application platform, the CellFX System is intended to offer customer value with a utilization-based revenue model across an expanding spectrum of clinical applications. To learn more, please visit www.pulsebiosciences.com.

Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

Caution: Pulse Biosciences’ CellFX System and Nano-Pulse Stimulation technology are for investigational use only.

Investors:

Pulse Biosciences

Sandra Gardiner, EVP and CFO

510-241-1077

[email protected]

or

Gilmartin Group

Philip Trip Taylor

415-937-5406

[email protected]

Media:

Tosk Communications

Nadine D. Tosk

504-453-8344

[email protected] or

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Medical Devices

MEDIA:

Posted on

First Trust Dynamic Europe Equity Income Fund Issues Notice Regarding December 2020 Distribution

First Trust Dynamic Europe Equity Income Fund Issues Notice Regarding December 2020 Distribution

WHEATON, Ill.–(BUSINESS WIRE)–
The Board of Trustees of First Trust Dynamic Europe Equity Income Fund (the “Fund”) (NYSE: FDEU), CUSIP 33740D107, previously approved a managed distribution policy for the Fund (the “Managed Distribution Plan”) in reliance on exemptive relief received from the Securities and Exchange Commission which permits the Fund to make periodic distributions of long-term capital gains as frequently as monthly each tax year.

The Fund has declared a distribution payable on December 15, 2020, to shareholders of record as of December 2, 2020, with an ex-dividend date of December 1, 2020. This Notice is meant to provide you information about the sources of your Fund’s distributions. You should not draw any conclusions about the Fund’s investment performance from the amount of its distribution or from the terms of its Managed Distribution Plan.

The following tables set forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date for the Fund from the following sources: net investment income (“NII”); net realized short-term capital gains (“STCG”); net realized long-term capital gains (“LTCG”); and return of capital (“ROC”). These estimates are based upon information as of November 30, 2020, are calculated based on a generally accepted accounting principles (“GAAP”) basis and include the prior fiscal year-end undistributed net investment income. The amounts and sources of distributions are expressed per common share.

 

 

 

 

 

 

 

 

 

 

 

 

 

5 Yr. Avg.

Annualized

Current

Annual

Total

Fund

Fund

Fiscal

Total Current

Current Distribution ($)

Current Distribution (%)

Dist. Rate as a

Return

Ticker

Cusip

Year End

Distribution

NII

STCG

LTCG

ROC (2)

NII

STCG

LTCG

ROC(2)

% of NAV(3)

on NAV(4)

FDEU

33740D107

12/31/2020

$0.06000

$0.02348

–

–

$0.03652

39.14%

–

–

60.86%

5.50%

1.52%

 
 

Total

Cumulative

Cumulative

Fiscal

Fund

Fund

Fiscal

Cumulative

Fiscal YTD

Cumulative Distributions Fiscal YTD ($)

Cumulative Distributions Fiscal YTD

(%)

Fiscal YTD

Distributions as

YTD Total

Return

Ticker

Cusip

Year End

Distributions(1)

NII

STCG

LTCG

ROC (2)

NII

STCG

LTCG

ROC(2)

a % of NAV(3)

on NAV(4)

FDEU

33740D107

12/31/2020

$0.96400

$0.37728

–

–

$0.58672

39.14%

–

–

60.86%

7.36%

-12.09%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes the most recent monthly distribution paid on December 15, 2020.

(2) The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income.”

(3) Based on Net Asset Value (“NAV”) as of November 30, 2020.

(4) Total Returns are through November 30, 2020.

The amounts and sources of distributions reported in this Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. You should not use this Notice as a substitute for your Form 1099-DIV.

First Trust Advisors L.P. (“FTA”) is a federally registered investment advisor and serves as the Fund’s investment advisor. FTA and its affiliate First Trust Portfolios L.P. (“FTP”), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services. FTA has collective assets under management or supervision of approximately $164 billion as of November 30, 2020 through unit investment trusts, exchange-traded funds, closed-end funds, mutual funds and separate managed accounts. FTA is the supervisor of the First Trust unit investment trusts, while FTP is the sponsor. FTP is also a distributor of mutual fund shares and exchange-traded fund creation units. FTA and FTP are based in Wheaton, Illinois.

Janus Capital Management LLC, a legal entity of Janus Henderson Investors, serves as the Fund’s investment sub-advisor. Janus Henderson Investors is headquartered in London and is a global investment management firm that provides a full spectrum of investment products and services to clients around the world. With offices in 28 cities with more than 2,200 employees, Janus Henderson Investors managed approximately $358.3 billion in assets as of September 30, 2020.

Past performance is no assurance of future results. Investment return and market value of an investment in the Fund will fluctuate. Shares, when sold, may be worth more or less than their original cost. There can be no assurance that the Fund’s investment objectives will be achieved. The Fund may not be appropriate for all investors.

Principal Risk Factors: The Fund is subject to risks, including the fact that it is a diversified closed-end management investment company.

Securities held by a fund, as well as shares of a fund itself, are subject to market fluctuations caused by factors such as general economic conditions, political events, regulatory or market developments, changes in interest rates and perceived trends in securities prices. Shares of a fund could decline in value or underperform other investments as a result of the risk of loss associated with these market fluctuations. In addition, local, regional or global events such as war, acts of terrorism, spread of infectious diseases or other public health issues, recessions, or other events could have a significant negative impact on a fund and its investments. Such events may affect certain geographic regions, countries, sectors and industries more significantly than others. The outbreak of the respiratory disease designated as COVID-19 in December 2019 has caused significant volatility and declines in global financial markets, which have caused losses for investors. The impact of this COVID-19 pandemic may last for an extended period of time and will continue to impact the economy for the foreseeable future.

Net investment income paid by the Fund to its shareholders is derived from the premiums it receives from writing (selling) call options and from the dividends and interest it receives from the equity securities and other investments held in the Fund’s portfolio and short-term gains thereon. Premiums from writing (selling) call options and dividends and interest payments made by the securities in the Fund’s portfolio can vary widely over time. Dividends on equity securities are not fixed but are declared at the discretion of an issuer’s board of directors. There is no guarantee that the issuers of the equity securities in which the Fund invests will declare dividends in the future or that if declared they will remain at current levels. The Fund cannot assure as to what percentage of the distributions paid on the common shares, if any, will consist of qualified dividend income or long-term capital gains, both of which are taxed at lower rates for individuals than are ordinary income and short-term capital gains.

Because the Fund will invest primarily in securities of non-U.S. issuers, which are generally denominated in non-U.S. currencies, there are risks not typically associated with investing in securities of U.S. issuers. Non-U.S. issuers are subject to higher volatility than securities of U.S. issuers. An investor may lose money if the local currency of a non-U.S. market depreciates against the U.S. dollar. The Fund may invest from time to time a substantial amount of its assets in issuers located in a single country or region.

Investments in securities of issuers located in emerging market countries are considered speculative and there is a heightened risk of investing in emerging markets securities. Financial and other reporting by companies and government entities also may be less reliable in emerging market countries. Shareholder claims that are available in the U.S., as well as regulatory oversight and authority that is common in the U.S., including for claims based on fraud, may be difficult or impossible for shareholders of securities in emerging market countries or for U.S. authorities to pursue.

On June 23, 2016, the United Kingdom voted via referendum to leave the EU, an event commonly referred to as “Brexit.” Brexit immediately led to significant market volatility around the world, as well as political, economic, and legal uncertainty. On January 31, 2020, the United Kingdom officially left the EU, which started a transition period for the United Kingdom and the EU to negotiate a wide variety of agreements, including a trade agreement. There is uncertainty relating to the precise terms of many of these agreements. At this time, it is also difficult to predict what the longer term ramifications and political, economic, and legal implications will be as a result of Brexit, including the impact on the Fund’s portfolio holdings. The impact on not only the United Kingdom and European economies, but the broader global economy, could be significant, potentially resulting in increased volatility and illiquidity and lower economic growth for companies that rely significantly on Europe for their business activities and revenues.

The Fund will engage in practices and strategies that will result in exposure to fluctuations in foreign exchange rates, thus subjecting it to foreign currency risk.

The market value of REIT shares and the ability of the REITs to distribute income may be adversely affected by several factors.

The Fund’s use of derivatives may result in losses greater than if they had not been used, may require the Fund to sell or purchase portfolio securities at inopportune times, may limit the amount of appreciation the Fund can realize on an investment, or may cause the Fund to hold a security that it might otherwise sell.

Use of leverage can result in additional risk and cost, and can magnify the effect of any losses.

In the event of conversion to an open-end management investment company, the Common Shares would cease to be listed on the NYSE or other national securities exchange, and such Common Shares would thereafter be redeemable at NAV at the option of the Common Shareholder, rather than traded in the secondary market at market price, which, for closed-end fund shares, may at times be at a premium to NAV. Any Borrowings or Preferred Shares of the Fund would need to be repaid or redeemed upon conversion and, accordingly, a portion of the Fund’s portfolio may need to be liquidated, potentially resulting in, among other things, lower current income.

The risks of investing in the Fund are spelled out in the shareholder reports and other regulatory filings.

The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.

Forward-Looking Statements

Certain statements made in this press release that are not historical facts are referred to as “forward‑looking statements” under the U.S. federal securities laws. Actual future results or occurrences may differ significantly from those anticipated in any forward‑looking statements due to numerous factors. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward‑looking statements, which generally are not historical in nature. Forward‑looking statements are subject to certain risks and uncertainties that could cause actual results to differ from those anticipated in any forward-looking statements. You should not place undue reliance on forward‑looking statements, which speak only as of the date they are made. The Fund undertakes no responsibility to update publicly or revise any forward‑looking statements.

Inquiries: Don Swade (630) 765-8661

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Logo
Logo
Posted on

Forma Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Forma Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

WATERTOWN, Mass.–(BUSINESS WIRE)–
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of an underwritten public offering of 6,095,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 795,000 shares of common stock, at a public offering price of $45.25 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $275.8 million. All of the shares in the offering were offered by Forma.

Jefferies, SVB Leerink and Credit Suisse acted as joint book-running managers for the offering. Oppenheimer & Co acted as lead manager for the offering.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer or sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

Registration statements relating to these securities became effective on December 10, 2020. The offering was made only by means of a prospectus, copies of which may be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388, or by email at [email protected]; SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at (800) 808-7525, ext. 6132, or by email at [email protected]; Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, NC 27560, by telephone at (800) 221-1037, or by email at [email protected]; or Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY, 10004, by telephone at (212) 667-8055, or by email at [email protected].

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Media Contact:

Kari Watson, +1 781-235-3060

MacDougall

[email protected]

Investor Contact:

Mario Corso

Forma Therapeutics

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Oncology Health Other Health General Health Pharmaceutical Biotechnology

MEDIA:

Logo
Logo